OR WAIT 15 SECS
January 08, 2021
Tone still set on the market catalysts to look for in 2021.
December 11, 2020
Vaccine strides, likely pricing impasse point to optimism for 2021.
November 16, 2020
Chief financial officers gather virtually to share the stories of directing their company IPOs over the finish line amid the COVID-19 pandemic.
Biopharma raises an unprecedented $100 billion.
October 14, 2020
When the people are the sole assets.
September 11, 2020
The key factors behind the sector’s strong surge in new equity fundraisings.
Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead.
August 11, 2020
Our latest review of biopharma financial performance reveals solid growth rates in enterprise value and rebounding value-to-sales numbers—proving once again the business imperative of regaining and sustaining shareholder value.
August 10, 2020
Latest reform brouhaha requires a united response focused on real solutions.
June 12, 2020
Now is the time, the world is listening.
